Search Within

Victoria Susana Blinder

Formats
  1. Journal Article (58)
  2. Meeting Abstract (46)
  3. Book Section (3)
  4. Review (2)
  5. Editorial (1)
  6. Guidelines (1)
Groups
  1. Breast Medicine Service (111)
  2. Department of Medicine (111)
  3. Immigrant Health and Cancer Disparities Service (111)
  4. Population Sciences Research Program (111)
  5. Psychiatry and Behavioral Sciences, Department of (111)
  6. Solid Tumor Oncology Division (111)

More Groups

People
  1. Francesca Gany (27)
  2. Sujata Patil (20)
  3. Ting Bao (10)
  4. Elena Elkin (9)
  5. Mark Robson (9)
  6. Carolyn Eberle (8)

More People

Years
  1. 2025 (7)
  2. 2024 (11)
  3. 2023 (5)
  4. 2022 (14)
  5. 2021 (11)
  6. 2020 (9)

More Years

Publications
  1. Journal of Clinical Oncology (37)
  2. Breast Cancer Research and Treatment (7)
  3. Cancer (7)
  4. Cancer Research (5)
  5. Psycho-Oncology (5)
  6. Quality of Life Research (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (39)
  2. Springer (18)
  3. American Association for Cancer Research (9)
  4. Wiley Blackwell (7)
  5. John Wiley & Sons (6)
  6. Oxford University Press (6)

More Publishers

Results (111)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prevalence and characterization of dermatologic adverse events related to alpelisib (BYL719) in breast cancer patients
    Meeting Abstract

    Barrios, D. M.; Wang, D. G.; Blinder, V. S.; Bromberg, J.; Drullinsky, P.; Funt, S. A.; Jhaveri, K. L.; Lake, D.; Lyons, T.; Modi, S.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Patient-reported benefit from proposed interventions to reduce financial hardship during cancer treatment
    Meeting Abstract

    Aviki, E.; Chino, F.; Ramirez, J.; Blinder, V. S.; Mueller, J. J.; Leitao, M. M.; Abu-Rustum, N.; Gany, F.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Disparities in work status after treatment for breast cancer: A controlled, longitudinal study
    Meeting Abstract

    Blinder, V. S.; Patil, S.; Eberle, C.; Jung, G.; Kampel, L. J.; Hwang, C.; Bao, T.; Robson, M. E.; Malik, M.; Gany, F.
    Cancer Epidemiology Biomarkers and Prevention (2020)

    Fulltext@MSK | Save
  • Determining the timing and frequency of financial toxicity assessments in oncology patients
    Meeting Abstract

    Thom, B.; Barrow, B.; Benedict, C.; Korenstein, D.; Tran, C.; Blinder, V. S.
    Annals of Behavioral Medicine (2020)

    Fulltext@MSK | Save
  • Dermatologic adverse events related to the PI3Kα inhibitor alpelisib (BYL719) in patients with breast cancer
    Journal Article

    Wang, D. G.; Barrios, D. M.; Blinder, V. S.; Bromberg, J. F.; Drullinsky, P. R.; Funt, S. A.; Jhaveri, K. L.; Lake, D. E.; Lyons, T.; Modi, S.; more...
    Breast Cancer Research and Treatment (2020)

    Fulltext@MSK | Save
  • Patient-reported outcomes (PROs) during one year of adjuvant enzalutamide for the treatment of early stage androgen receptor positive (AR+) triple negative breast cancer
    Meeting Abstract

    Traina, T. A.; Jones, L. W.; Blinder, V.; Scott, J.; Boyle, L. A.; Arumov, A.; Alano, T.; Patil, S.; DeFusco, P.; Lamparella, N.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Impact of cancer on employment
    Review

    Blinder, V. S.; Gany, F. M.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A technology-assisted, brief mind-body intervention to improve the waiting room experience: Randomized quality improvement study
    Journal Article

    Bao, T.; Deng, G.; DeMarzo, L. A.; Zhi, W. I.; DeRito, J. L.; Blinder, V.; Chen, C.; Li, Q. S.; Green, J.; Pendleton, E.; more...
    JMIR Cancer (2019)

    Fulltext@MSK | Save
  • Exercise trends among previously non-exercising breast cancer survivors: Analysis of an ethnically diverse sample
    Meeting Abstract

    Oza, S.; Blinder, V. S.; Tran, C.; Patil, S.; Gany, F.; Roberts, N.; Kampel, L. J.; Malik, M.; Bao, T.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Phase 1 study of LY3022855, a colony-stimulating factor-1 receptor (CSF-1R) inhibitor, in patients with metastatic breast cancer (MBC) or metastatic castration-resistant prostate cancer (MCRPC)
    Meeting Abstract

    Autio, K. A.; Klebanoff, C. A.; Schaer, D.; Kauh, J. S.; Slovin, S. F.; Blinder, V. S.; Comen, E. A.; Danila, D. C.; Hoffman, D. M. J.; Kang, S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save